News & Blog

January 31, 2024 | Blog Post
MEC in 4Q23: Pioneering the Future of Precision Medicine – More in 2024
Read More
January 18, 2024 | Press Release
Immunitas Therapeutics Appoints Annalisa D’Andrea, Ph.D., as Chief Scientific Officer
Read More
January 08, 2024 | Press Release
Pleno Deploys its RAPTOR Instrument Platform Available with TotalSeq™ Antibodies from BioLegend
Read More
January 05, 2024 | In The News
SonoThera’s CEO Ken Greenberg interviewed by Wilson Sonsini’s Dustin Luettgen in the latest edition of the Life Sciences Report
Read More
November 02, 2023 | Press Release
ProJenX Announces Initial Closing of $15M Series A Financing and Appoints Rick Hartz to Board of Directors
Read More
November 01, 2023 | Press Release
Immunitas Therapeutics Presents Data for Novel Anti CLEC2D-TLR9 Conjugate Program at the Society for Immunotherapy of Cancer 2023 Annual Meeting
Read More
October 30, 2023 | Press Release
AVILAR THERAPEUTICS TO PRESENT NEW DATA FOR ATAC EXTRACELLULAR PROTEIN DEGRADERS AT TARGETED PROTEIN DEGRADATION SUMMIT
Read More
October 19, 2023 | Press Release
FDA Grants Fast Track Designation to ANPD001, Autologous Investigational Cell Therapy for the Treatment of Parkinson’s Disease
Read More
September 21, 2023 | Press Release
Nobias Therapeutics Announces Acceptance of Late-Breaking Abstract and Presentation of Phase 2 Clinical Data for NB-001 at 52nd Child Neurology Society Annual Meeting
Read More
September 19, 2023 | Press Release
AVILAR THERAPEUTICS TO PRESENT AT UPCOMING INDUSTRY CONFERENCES
Read More